Beacon Study
Currently Recruiting
22 Nov 2026
Up to $3,500
Melbourne, Australia
This study is evaluating a new oral medication being developed for plaque psoriasis and includes a total of 4 nights in the clinic and 5 follow-up visits.
Plaque psoriasis is a long-term skin condition that can cause raised, dry, and itchy patches of skin.
Researchers are exploring whether this new medication may offer a different approach to treatment. The information collected during this study will help researchers better understand how the medication behaves in the body and support future research in people living with plaque psoriasis.
This study is sponsored by a pharmaceutical company.
Join our clinical trial
This is a first-in-human (FIH) study, meaning it is the first time the investigational treatment is being tested in people. The study has been carefully designed with strict safety protocols and has been approved by an independent ethics committee. It is not known whether the study drug may cause unexpected, serious, or life-threatening side effects. While these are considered unlikely, you will be carefully monitored throughout the study and provided with prompt treatment if any such effects occur.
Before joining, you’ll receive detailed information about the study, meet with a doctor, and have the chance to ask any questions.
What to expect
- Participation in a monitored clinical environmentÂ
- Study visits scheduled Â
- Support from a professional medical teamÂ
- Reimbursement for your time and commitmentÂ
Study schedule
| Intake 1 | In-clinic stay:
Stay 1 22 November 2026- 24 November 2026 Stay 2 13 December 2026- 15 December 2026 |
Follow-up visits:
25 November 2026
26 November 2026 16 December 2026
17 December 2026
20 December 2026
|
Study dates are subject to change. Our team will confirm details with you during the screening process.
Trial details
Study duration
- 2 x 2 nights stay
- 5 follow-up visits
Study medication
The study drug is administered via an oral capsule.
Additional eligibility
- Non-smokersÂ
- Not pregnant or breastfeeding  Â
- Willing to follow contraception guidelines (If applicable)Â Â
- Willing and able to attend all study visits and follow instructions  Â
Ethics
An independent ethics committee has approved this clinical trial.
Are you a match?
Age
18 - 55 years old
Remuneration
Up to $3,500 *with screening reimbursement.
Full details outlined in consent form.
Gender
Male, Female, Female (Post-menopausal) or Female of non-childbearing potential
BMI
BMI 18 - 32 kg/m2
Commitment
4 nights, 5 clinic visits
Medical condition
Not taking any medications